Search terms
Results 51 - 60 of 152 - ordered by :
Pages: 1 ... 3 4 5 6 7 8 9 ... 16

About 90% of type 2 diabetes is attributed to excess weight, which is present in 1.1 billion adults worldwide, and in westernized urban populations the prevalence of diabetes ranges from 14 to 20%.1 ...

European Heart Journal, Chesebro, James H.

Date : 01/09/2008 Item size : 150716 bytes

Dual antiplatelet therapy is the mainstay of antiplatelet treatment in percutaneous coronary interventions (PCIs) with stent implantation, as well as in acute coronary syndromes (ACS) with and ...

European Heart Journal, Schiele, Francois, Meneveau, Nicolas, Bassand, Jean-Pierre

Date : 01/06/2008

14:00 P6496 Dual antiplatelet therapy improves the levels of CD34+ progenitor cells exrpessing endothelial phenotype as well as their conjugates with platelets in patients with acute coronary ...

Poster session 7: Platelets and antiplatelet therapy: Miscellaneous

Date : 02/09/2014 Item size : 93593 bytes

08:30 P5531 A study of platelet inhibition, using a 'point of care' platelet function test, following primary percutaneous coronary intervention for st-elevation myocardial infarction (PINPOINT-PPCI) ...

Poster session 6: Thrombosis and antithrombotic therapy: miscellaneous

Date : 02/09/2014 Item size : 103233 bytes

Luis Alberto GARCIA RODRIGUEZ (Madrid, ES) 08:30 P4860 Do changes in high on-treatment platelet reactivity predict cardiovascular events in patients undergoing percutaneous coronary intervention? A ...

Poster Session 6: Thrombosis and antithrombotic therapy

Date : 03/09/2013 Item size : 408495 bytes

08:30 P1475 Determinants of post-discharge bleeding events in ACS patients during antiplatelet therapy: insight from the A-MATCH trial Young-Hoon JEONG (Jinju, Korea, Republic of) 08:30 P1476 Vitamin ...

Poster session 2: Platelets and antiplatelets therapy II

Date : 30/08/2015 Item size : 92668 bytes

10:05 P5000 Platelet responsiveness to PAR4 activation in a healthy population and its inhibition by a potent and selective PAR4 antagonist Kate DOWNES (Cambridge, United Kingdom) 10:12 P5001 The ...

Mechanisms of platelet activation

Date : 30/08/2016 Item size : 84152 bytes

Edyta STODOLKIEWICZ (Krakow, Poland) 08:30 P5595 Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with ...

Poster session 6: Antiplatelet therapy

Date : 30/08/2016 Item size : 164308 bytes

08:30 P3406 Eight-year clinical outcome of sirolimus-eluting stent implantation for small vessel disease Mizuki MIURA (Kitakyushu, Japan) 08:30 P3407 Paclitaxel- versus zotarolimus-eluting stents in ...

Poster session 4: Impact of stent design on post PCI outcomes

Date : 29/08/2016 Item size : 142798 bytes

Insights from a single center PCI registry Roxana MEHRAN (New York, United States of America) 08:30 P1511 Association of a reduced antiplatelet activity of CYP3A4-metabolized statin with clinical ...

Poster session 2: Miscellaneous

Date : 30/08/2015 Item size : 107075 bytes